Evidence map›Paper›PMID 33251488›Full record

ArticleACS applied bio materials2020

Experimental Single-Platform Approach to Enhance the Functionalization of Magnetically Targetable Cells.

Mark R Battig, Ivan S Alferiev, David T Guerrero, Ilia Fishbein, Benjamin B Pressly, Robert J Levy, Michael Chorny

Open access · greenAbstract read
In one paragraph

Article in ACS applied bio materials, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 95% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Mark R BattigDepartment of Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
Ivan S AlferievDepartment of Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
David T GuerreroDepartment of Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
Ilia FishbeinDepartment of Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
Benjamin B PresslyDepartment of Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
Robert J LevyDepartment of Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
Michael ChornyDepartment of Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
Children's Hospital of Philadelphia · US

Funding

Training in Molecular Therapeutics for Pediatric CardiologyT32HL007915 · NHLBI · CHILDREN'S HOSP OF PHILADELPHIA · PI Robert J Levy, JOSEPH W ROSSANO · 1999 to 2026
$13.4M
Uniform field controlled magnetic cell targeting to stentsR01HL111118 · NHLBI · CHILDREN'S HOSP OF PHILADELPHIA · PI CHORNY, MICHAEL · 2012 to 2016
$2.1M
Integrated drug-in-cell therapy of in-stent restenosisR21HL131016 · NHLBI · CHILDREN'S HOSP OF PHILADELPHIA · PI CHORNY, MICHAEL · 2016 to 2017
$462k
NHLBI NIH HHS R01 HL111118NHLBI NIH HHS R21 HL131016NHLBI NIH HHS T32 HL007915
6 · The paper itself

Abstract

Magnetic guidance shows promise as a strategy for improving the delivery and performance of cell therapeutics. However, clinical translation of magnetically guided cell therapy requires cell functionalization protocols that provide adequate magnetic properties in balance with unaltered cell viability and biological function. Existing methodologies for characterizing cells functionalized with magnetic nanoparticles (MNP) produce aggregate results, both distorted and unable to reflect variability in either magnetic or biological properties within a preparation. In the present study, we developed an inverted-plate assay allowing determination of these characteristics using a single-platform approach, and applied this method for a comparative analysis of two loading protocols providing highly uniform

Indexed as

cell deliverycell functionalizationendothelial cellsmagnetic nanoparticlemagnetic targetingsingle-platform assay

Identifiers

PMID33251488
PMCPMC7687866
OpenAlexW3026501062

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.